Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

BACKGROUND: Cancer patients are considered highly vulnerable to the COVID-19 pandemic. However, delaying cancer-specific therapies could have a deleterious effect on survival. The potential suppressive effects of chemotherapies or cancer-related microenvironment raised the question on how cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansi, Laura, Spehner, Laurie, Daguindau, Etienne, Bouiller, Kevin, Almotlak, Hamadi, Stein, Ulrich, Bouard, Adeline, Kim, Stefano, Klajer, Elodie, Jary, Marine, Meynard, Guillaume, Vienot, Angélique, Nardin, Charlée, Bazan, Fernando, Lepiller, Quentin, Westeel, Virginie, Adotévi, Olivier, Borg, Christophe, Kroemer, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997727/
https://www.ncbi.nlm.nih.gov/pubmed/33882374
http://dx.doi.org/10.1016/j.ejca.2021.03.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997727/
https://www.ncbi.nlm.nih.gov/pubmed/33882374
http://dx.doi.org/10.1016/j.ejca.2021.03.033

Ejemplares similares